Moveshelf participates in MyoStride to co-develop a user-friendly, affordable and reliable EMG-driven musculoskeletal modeling for estimating muscle function during rehab
As part of our commitment to unlock clinician-friendly quantitative, personalized care of movement disorders with various measuring technologies, we are excited to share that we are participating in the MyoStride project together with TMSi (an Artinis company), the University of Twente and the Sint Maartenskliniek, funded by the EFRO Oost program of European Regional Development Fund.
In the Netherlands, 265.000 patients with neurological or neuromuscular disorders face mobility issues due to, among other things, reduced muscle function in the lower legs. Although rehabilitation is beneficial, the effectiveness of treatment cannot easily be assessed and is based mainly on observations, leading to suboptimal recovery. To overcome this limitation, in MyoStride we co-develop a wearable device and Software algorithms to quantify the activity of muscle groups in the lower leg during rehabilitation. The device is based on an earlier prototype developed during the predecessor project GUTs.
The goal of the current project is to further develop the device prototype, improve the algorithms, simplify the calibration and rely on Moveshelf Information System for interpretation, reporting and integration with clinical IT systems.
Are you interested in hearing more about Moveshelf and our R&D efforts? Please contact us at hello@moveshelf.com.